Ohio High-Tech

Daniel Charles's article, "States Wrestle Over Measuring The Value Of High-Tech Development" (The Scientist, March 20, 1989, page 6) touches on some important questions for those sponsoring technology development initiatives. Unfortunately, the article misrepresented Ohio's approach to program assessment, and some of the statements I made on the matter were taken out of context. It is true that measurement of results from technology development programs is an important issue for many states and

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

It is true that measurement of results from technology development programs is an important issue for many states and to the business and scientific communities they serve. The long-term objectives and benefits of these initiatives make it difficult to show immediate economic payoffs, which are needed to generate the continual financing that is crucial to their success.

Charles's article leads one to believe that Ohio's Thomas Edison Program assessed its research centers totally on the basis of job creation (or only short-term results), but then decided to "pull away" from such an assessment strategy once the numbers were in. This could not be further from the truth. Job creation was only one of nine criteria that Ohio used to judge the centers' performance.

The nine criteria—taken as a whole—portray the Ohio centers' overall health and performance. The decision to focus on nine performance measures was made specifically so that Ohio ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Christopher Coburn

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours